Lumibird SA (LBIRD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Lumibird SA (LBIRD) operates in the Diagnostics & Research industry and is headquartered in Lannion, France with about 1,078 employees. Its market capitalization is roughly €626 million. In the fiscal year ended 2025-12-31, LBIRD reported €228M in revenue and €14M in net income.

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions.

Interactive charts & full statements →

LBIRD Revenue & Earnings History — Annual Income Statement

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LBIRD Free Cash Flow History

LBIRD Balance Sheet History

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LBIRD viewer.

Other Companies in Diagnostics & Research

• 6667 · Mega Genomics Limited — $2 billion
• PSNL · Personalis, Inc. — $2 billion
• OPK · OPKO Health, Inc. — $1 billion
• CSTL · Castle Biosciences, Inc. — $979 million
• FLGT · Fulgent Genetics, Inc. — $527 million
• EDT · Spectral Medical Inc. — $405 million
• IDHC · Integrated Diagnostics Holdings plc — $311 million
• MYGN · Myriad Genetics, Inc. — $290 million

About TickerBase · Data methodology & sources · Privacy · Terms